TRAVERE THERAPEUTICS, INC. Inventory, Work in Process, Net of Reserves
TRAVERE THERAPEUTICS, INC. (TVTX) had Inventory, Work in Process, Net of Reserves of $7.89 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-08-04
- 2026-06-30: Inventory, Work in Process, Net of Reserves $7.89M.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $3.91M.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $2.35M.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $1.99M.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2026-06-30 | $7.89M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $3.91M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $2.35M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.99M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $2.09M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.44M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $7.63M 10-K · filed 2026-02-19 |
| 2024-09-30 | $5.56M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $5.53M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $9.33M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $4.73M 10-K · filed 2025-02-21 |
| 2023-09-30 | $972.00K 10-Q · filed 2023-11-07 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-20 |
| 2022-09-30 | $857.00K 10-Q · filed 2022-10-27 |
| 2022-06-30 | $653.00K 10-Q · filed 2022-08-04 |
| 2021-12-31 | $255.00K 10-Q · filed 2022-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |